Plant Formulation ATRICOV 452 in Improving the Level of COVID-19 Specific Inflammatory Markers in Patients
Latha Damle, Hrishikesh Damle, BR Bharath
doi: https://doi.org/10.1101/2021.10.07.21264491
Latha Damle
1Computational Biology, Atrimed Biotech LLP, Banglore, 560100, India
Hrishikesh Damle
2Atrimed Pharmaceuticals Pvt. Ltd, Banglore, 560001, India
BR Bharath
1Computational Biology, Atrimed Biotech LLP, Banglore, 560100, India
Data Availability
The data is archived, available at trial site and with the sponsor.
Posted October 09, 2021.
Plant Formulation ATRICOV 452 in Improving the Level of COVID-19 Specific Inflammatory Markers in Patients
Latha Damle, Hrishikesh Damle, BR Bharath
medRxiv 2021.10.07.21264491; doi: https://doi.org/10.1101/2021.10.07.21264491
Subject Area
Subject Areas
- Addiction Medicine (313)
- Allergy and Immunology (616)
- Anesthesia (158)
- Cardiovascular Medicine (2257)
- Dermatology (201)
- Emergency Medicine (368)
- Epidemiology (11550)
- Forensic Medicine (10)
- Gastroenterology (676)
- Genetic and Genomic Medicine (3542)
- Geriatric Medicine (336)
- Health Economics (612)
- Health Informatics (2287)
- Health Policy (910)
- Hematology (333)
- HIV/AIDS (742)
- Medical Education (357)
- Medical Ethics (100)
- Nephrology (386)
- Neurology (3327)
- Nursing (190)
- Nutrition (504)
- Oncology (1748)
- Ophthalmology (523)
- Orthopedics (208)
- Otolaryngology (283)
- Pain Medicine (222)
- Palliative Medicine (66)
- Pathology (436)
- Pediatrics (998)
- Primary Care Research (399)
- Public and Global Health (5975)
- Radiology and Imaging (1216)
- Respiratory Medicine (807)
- Rheumatology (367)
- Sports Medicine (311)
- Surgery (383)
- Toxicology (50)
- Transplantation (170)
- Urology (142)